Skip to main content
TipRanks
Go Ultimate75% OFF

Omega Diagnostics (RVKA) AI Stock Analysis

0 Followers
DE:RVKA

Omega Diagnostics

(Frankfurt:RVKA)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Low leverageThe company carries very little debt relative to equity, reducing financial risk and interest-related pressure. This conservative capital structure preserves flexibility to manage volatility, fund operations, or pursue development without the constraints associated with heavier borrowing.
Negative Factors
Revenue contractionThe recent return to revenue contraction after the 2024 rebound points to an unstable top-line trajectory. Sustained declines can weaken scale benefits, reduce the resources available for product development, and make it harder to absorb fixed operating costs across the business.

Omega Diagnostics (RVKA) vs. iShares MSCI Germany ETF (EWG)

-40%-20%0%20%40%60%80%DE:RVKA-29.41%EWG+4.05%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 3.45M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.6
Beta (1Y)
0.52
Revenue Growth
-33.83%
EPS Growth
-536.23%
Country
Germany
Employees
85
Sector
Healthcare
Sector Strength
51
Industry
Medical - Instruments & Supplies

Omega Diagnostics Business Overview & Revenue Model

Company Description

Established in 1987 and headquartered in London, UK, Cambridge Nutritional Sciences plc (formerly Omega Diagnostics Group PLC until its name change in September 2023) is a specialist in the development, manufacturing, and supply of medical diagnostic...

Omega Diagnostics Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:RVKA against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:TSTLGB:TSTL80OutperformGBP 185.08M23.0823.05%3.69%10.02%19.83%
GB:AMSGB:AMS71OutperformGBP 616.74M166.471.44%1.66%6.05%-60.00%
GB:EKFGB:EKF64NeutralGBP 100.14M40.343.58%―2.26%-57.04%
GB:IXIGB:IXI55NeutralGBP 27.92M-6.50-16.18%―13.04%15.88%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
GB:ABDXGB:ABDX46NeutralGBP 21.48M-15.45-34.31%―30.42%43.16%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%75%DE:RVKAGB:AMSGB:EKFGB:IXIGB:TSTLGB:ABDXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:RVKA and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:RVKAOmega Diagnostics0.01-0.01-29.41%
GB:AMSAdvanced Medical Solutions283.0075.4236.33%
GB:EKFEKF Diagnostics Holdings23.90-0.60-2.45%
GB:IXIIXICO plc13.002.4022.64%
GB:TSTLTristel plc385.0043.4812.73%
GB:ABDXAbingdon Health PLC8.501.2517.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.